GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (HKSE:01466) » Definitions » Long-Term Debt

Baijin Life Science Holdings (HKSE:01466) Long-Term Debt : HK$39.77 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Baijin Life Science Holdings Long-Term Debt?

Baijin Life Science Holdings's Long-Term Debt for the quarter that ended in Sep. 2024 was HK$39.77 Mil.

Baijin Life Science Holdings's quarterly Long-Term Debt increased from Sep. 2023 (HK$0.00 Mil) to Mar. 2024 (HK$39.71 Mil) and increased from Mar. 2024 (HK$39.71 Mil) to Sep. 2024 (HK$39.77 Mil).

Baijin Life Science Holdings's annual Long-Term Debt stayed the same from Mar. 2022 (HK$0.00 Mil) to Mar. 2023 (HK$0.00 Mil) but then increased from Mar. 2023 (HK$0.00 Mil) to Mar. 2024 (HK$39.71 Mil).


Baijin Life Science Holdings Long-Term Debt Historical Data

The historical data trend for Baijin Life Science Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baijin Life Science Holdings Long-Term Debt Chart

Baijin Life Science Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 39.71

Baijin Life Science Holdings Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 39.71 39.77

Baijin Life Science Holdings  (HKSE:01466) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Baijin Life Science Holdings Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Baijin Life Science Holdings Business Description

Traded in Other Exchanges
Address
66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.
Executives
Pacific Wish Limited
Chan Vincent Wing Sing
Hui Ka Man Emily
Su Yaoyao 2201 Interest of corporation controlled by you
Ketto Inform Limited 2101 Beneficial owner

Baijin Life Science Holdings Headlines

No Headlines